Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219,882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors.
Zhao Y, Ma Y, Zang A, Cheng Y, Zhang Y, Wang X, Chen Z, Qu S, He J, Chen C, Jin C, Zhu D, Li Q, Liu X, Su W, Ba Y, Hao Y, Chen J, Zhang G, Qu S, Li Y, Feng W, Yang M, Liu B, Ouyang W, Liang J, Yu Z, Kang X, Xue S, Yang G, Yan W, Yang Y, Liu Z, Peng Y, Fanslow B, Huang X, Zhang L, Zhao H. Zhao Y, et al. Among authors: li y, li q. J Hematol Oncol. 2023 May 8;16(1):50. doi: 10.1186/s13045-023-01445-1. J Hematol Oncol. 2023. PMID: 37158938 Free PMC article. Clinical Trial.
Cancer immunotherapy: stress proteins and hyperthermia.
Manjili MH, Wang XY, Park J, Macdonald IJ, Li Y, Van Schie RC, Subjeck JR. Manjili MH, et al. Among authors: li y. Int J Hyperthermia. 2002 Nov-Dec;18(6):506-20. doi: 10.1080/02656730110116696. Int J Hyperthermia. 2002. PMID: 12537751 Free article. Review.
Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer.
Zhang C, Zhou F, Zou J, Fang Y, Liu Y, Li L, Hou J, Wang G, Wang H, Lai X, Xie L, Jiang J, Yang C, Huang Y, Chen Y, Zhang H, Li Y. Zhang C, et al. Among authors: li y, li l. Front Oncol. 2024 Jan 16;13:1322078. doi: 10.3389/fonc.2023.1322078. eCollection 2023. Front Oncol. 2024. PMID: 38293701 Free PMC article. Review.
NK cells as powerful therapeutic tool in cancer immunotherapy.
Huang M, Liu Y, Yan Q, Peng M, Ge J, Mo Y, Wang Y, Wang F, Zeng Z, Li Y, Fan C, Xiong W. Huang M, et al. Among authors: li y. Cell Oncol (Dordr). 2024 Jan 3. doi: 10.1007/s13402-023-00909-3. Online ahead of print. Cell Oncol (Dordr). 2024. PMID: 38170381 Review.
[Present status and advances in lung cancer stem cells.].
Li Y, Wu Z, Wang X. Li Y, et al. Zhongguo Fei Ai Za Zhi. 2008 Jun 20;11(3):473-6. doi: 10.3779/j.issn.1009-3419.2008.03.032. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20731959 Free article. Chinese. No abstract available.
219,882 results
You have reached the last available page of results. Please see the User Guide for more information.